Skip to content

The Effect of Pulsed Electromagnetic Field Therapy on Patients With Low Back Pain

The Effect of Pulsed Electromagnetic Field Therapy on Patients With Low Back Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03053375
Enrollment
80
Registered
2017-02-15
Start date
2017-02-08
Completion date
2018-06-30
Last updated
2017-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

This study will examine the effects of a portable of pulsed electromagnetic field (PEMF) device (MD Cure, Aerotel, USA) compared with a sham device on patient-reported outcomes of pain and function in patients with either acute/subacute or chronic low back pain (LBP).

Detailed description

This study is a double-blind, placebo-controlled, randomized pilot study comparing usual care + PEMF with usual care + sham. The investigators will recruit patients with LBP from the University of Bridgeport chiropractic clinic, and will enroll 80 total subjects: 40 with acute or subacute LBP, and 40 with chronic LBP. Within each of those populations the investigators will assign 20 subjects to receive usual care + PEMF, and 20 to receive usual care + sham. The investigators will track any other treatments initiated or discontinued during the trial. Patients who agree to participate with be randomly given a functional PEMF device or a sham unit. Patients and clinicians will be blinded to the assignment. All subjects will be given the same instructions for daily use of the devices, and will continue to receive usual follow-up at the UBCC clinic as indicated. The investigators will collect patient-reported measures of pain and function pain at baseline, 6 weeks, and 12 weeks, and will collect data on adverse effects at each visit and at 6 and 12 weeks.

Interventions

DEVICEMDCure

Battery powered portable pulsed electromagnetic therapy device

Sponsors

University of Bridgeport
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* UBCC patient * complaint of LBP intensity 4/10 or greater on the Numerical Rating Scale * diagnosis of a mechanical LBP condition * age 18-70 years * fluency in written and spoken English * for female subjects, be postmenopausal, surgically sterile, abstinent, or agree to practice an effective method of birth control for the duration of the study if sexually active * a willingness to participate in the study as evidenced by a signed informed consent form

Exclusion criteria

* current LBP complaint of 3/10 or less on the Numerical Rating Scale * diagnosis or suspicion of LBP caused by cancer, infection, referred visceral pain, inflammatory arthropathy, or other non-mechanical process * current or planned pregnancy * any electrically-based implanted devices such as pacemakers defibrillators, spinal cord stimulators, insulin pumps; metallic implants (e.g. surgical fusion constructs, disc replacements) in the low back * status post any lumbosacral spine surgery; significant mental health co-morbidities such as severe depression, schizoaffective disorders, suicidal ideation * inability to understand and/or complete all components of the informed consent process without the assistance of another person (e.g. without proxy) * inability to adhere to and comply with the treatment protocol.

Design outcomes

Primary

MeasureTime frameDescription
Change in pain intensityBaseline, weeks 6 and 12Numerical Rating Scale
Change in low back pain related disabilityBaseline, weeks 6 and 12Oswestry Disability Index

Countries

United States

Contacts

Primary ContactAnthony J Lisi
alisi@bridgeport.edu203-576-4437

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026